We present three patients with COVID-19 who developed acute renal failure during hospitalization and were seen to have an improvement in their kidney function after being started on therapeutic anticoagulation with heparin (Target PTT 58鈥 93seconds) for varying indications (atrial fibrillation, ...
Therapeutic anticoagulation with heparin in critically ill patients with COVID-19 N Engl J Med, 385 (2021), pp. 777-789 Google Scholar 5 L.C. Godoy, M.D. Neal, E.C. Goligher, et al. Heparin dose intensity and organ support-free days in patients hospitalized for COVID-19 JACC: Adv...
Therapeutic anticoagulation with heparin in noncritically ill patients with Covid-19. N Engl J Med. 2021;385(9):790-802. doi:10.1056/NEJMoa2105911PubMedGoogle ScholarCrossref 3. Sholzberg M, Tang GH, Rahhal H, et al; RAPID Trial Investigators. Effectiveness of therapeutic ...
Therapeutic anticoagulation with heparin in noncritically ill patients with Covid-19. N. Engl. J. Med. 385, 790–802 (2021). Article Google Scholar Ramacciotti, E. et al. Rivaroxaban versus no anticoagulation for post-discharge thromboprophylaxis after hospitalisation for COVID-19 (MICHELLE): ...
Therapeutic anticoagulation with heparin in noncritically ill patients with COVID-19. N Engl J Med. 2021;385(9):790-802. doi:10.1056/NEJMoa2105911PubMedGoogle Scholar 17. Sadeghipour P, Talasaz AH, Rashidi F, et al; INSPIRATION Investigators. Effect of intermediate-dose vs...
Patients who underwent therapeutic anticoagulation with a heparin infusion or enoxaparin (1mg/kg BID) were evaluated for neurologic deterioration or hemorrhage extension by CT scan. Results:There were 42 patients with a traumatic intracranial hemorrhage that subsequently developed a thrombotic complication....
The anticoagulation properties of the new agents are being characterised in experimental studies. Some of them have been advanced to large scale clinical trials and their effectiveness, and sometimes relative ineffectiveness,in arterial and venous thromboembolic disorders has been demonstrated. They are ...
Anticoagulation with heparin was used in one of the unsuccessful cases. In two cases, UGC was used to close a small active region that did not completely thrombose after thrombin injection. There were two patients who had recurrence of pseudoaneurysm the day after successful injection and ...
Anticoagulation with heparin was used in one of the unsuccessful cases. In two cases, UGC was used to close a small active region that did not completely thrombose after thrombin injection. There were two patients who had recurrence of pseudoaneurysm the day after successful injection and ...
Initial anticoagulation in patients with pulmonary embolism: thrombolysis, unfractionated heparin, LMWH, fondaparinux, or DOACs? Br. J. Clin. Pharmacol. 83, 2356–2366 (2017). CAS PubMed PubMed Central Google Scholar Wiviott, S. D. et al. Prasugrel versus clopidogrel in patients with acute ...